Literature DB >> 20932115

Role of myeloperoxidase in cardiology.

Baris Ikitimur1, Bilgehan Karadag.   

Abstract

Myeloperoxidase (MPO) is an enzyme found in myeloid cells, particularly in neutrophils, and to a lesser extent in monocytes and tissue macrophages. MPO plays an important role in the host defense against bacteria and viruses. Since MPO is also an important enzyme in the inflammatory process, and inflammation is a key component in the development and progression of atherosclerotic and other forms of cardiovascular disease, there is ongoing interest in the use of MPO as a biomarker in different fields of cardiology. We aimed to review the current state of literature regarding the role of MPO in cardiovascular disease, especially highlighting the practical implications of the fast growing data from clinical studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932115     DOI: 10.2217/fca.10.75

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  7 in total

1.  Neutrophilic inflammatory response and oxidative stress in premenopausal women chronically exposed to indoor air pollution from biomass burning.

Authors:  Anirban Banerjee; Nandan Kumar Mondal; Debangshu Das; Manas Ranjan Ray
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 2.  Molecular explanation of Wnt/βcatenin antagonist pyrvinium mediated calcium equilibrium changes in aging cardiovascular disorders.

Authors:  Khalid Saad Alharbi; Yogendra Singh; Obaid Afzal; Abdulmalik Saleh Alfawaz Altamimi; Imran Kazmi; Fahad A Al-Abbasi; Sami I Alzarea; Dinesh Kumar Chellappan; Sachin Kumar Singh; Kamal Dua; Gaurav Gupta
Journal:  Mol Biol Rep       Date:  2022-09-15       Impact factor: 2.742

3.  Bioinformatic Analysis for Potential Biomarkers and Therapeutic Targets of T2DM-related MI.

Authors:  Chan Li; Zhaoya Liu
Journal:  Int J Gen Med       Date:  2021-08-10

4.  Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.

Authors:  Franck Duclos; Lynn M Abell; David G Harden; Kristen Pike; Kimberly Nowak; Gregory A Locke; Gerald J Duke; Xiaoqin Liu; Gayani Fernando; Scott A Shaw; Benjamin P Vokits; Nicholas R Wurtz; Andrew Viet; Meriah N Valente; Sylwia Stachura; Paul Sleph; Javed A Khan; Ji Gao; Ashok R Dongre; Lei Zhao; Ruth R Wexler; David A Gordon; Ellen K Kick
Journal:  Medchemcomm       Date:  2017-10-26       Impact factor: 3.597

5.  Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).

Authors:  Nilminie Rathnayake; Anders Gustafsson; Anna Norhammar; Barbro Kjellström; Björn Klinge; Lars Rydén; Taina Tervahartiala; Timo Sorsa
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

6.  Serum myeloperoxidase level is associated with heart-type fatty acid-binding protein but not troponin T in patients with chronic heart failure.

Authors:  Omer Gedikli; Abdulkadir Kiris; Yusuf Hosoglu; Caner Karahan; Sahin Kaplan
Journal:  Med Princ Pract       Date:  2014-11-15       Impact factor: 1.927

7.  Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.

Authors:  Mehdi Baseri; Ramin Heidari; Behzad Mahaki; Yaghoub Hajizadeh; Amir Momenizadeh; Masoumeh Sadeghi
Journal:  Adv Biomed Res       Date:  2014-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.